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Background. Close therapeutic drug monitoring of Cyclosporine (CsA) in transplant outpatients is a favourable procedure to
maintain the long-term blood drug levels within their respective narrow therapeutic ranges. Compared to basal levels (C0), CsA
peaklevels(C2)aremorepredictivefortransplantrejection.However,theapplicationofC2 levelsishamperedbytheprecisetimeof
blood sampling and the need of qualiﬁed personnel. Therefore, we evaluated a new C2 self-obtained blood sampling in transplant
outpatients using dried capillary and venous blood samples and compared the CsA levels, stability, and clinical practicability of
the diﬀerent procedures. Methods. 55 solid organ transplant recipients were instructed touse single-handed sampling of each 50
μL capillary blood and dried blood spots by ﬁnger prick using standard ﬁnger prick devices. We used standardized EDTA-coated
capillary blood collection systems and standardized ﬁlter paper WS 903. CsA was determined by LC-MS/MS. The patients and
technicians also answered a questionnaire on the procedure and sample quality. Results. The C0 and C2 levels from capillary
blood collection systems (C0 [ng/mL]: 114.5 ± 44.5; C2: 578.2 ± 222.2) and capillary dried blood (C0 [ng/mL]: 175.4 ± 137.7; C2:
743.1 ± 368.1) signiﬁcantly (P<. 01) correlated with the drug levels of the venous blood samples (C0 [ng/mL]: 97.8 ± 37.4; C2:
511.2±201.5). The correlation at C0 was ρcap.-ven. = 0.749, and ρdried blood-ven = 0.432; at C2: ρcap.-ven. = 0.861 and ρdried blood-ven = 0.711. The
patientspreferredthedriedbloodsamplingbecauseofthemoresimpleandlesspainfulprocedure.Additionally,thesamplequality
of self-obtained dried blood spots for LC-MS/MS analytics was superior to the respective capillary blood samples. Conclusions.C 2
self-obtained dried blood sampling can easily be performed by transplant outpatients and is therefore suitable and cost-eﬀective
for close therapeutic drug monitoring.
1.Introduction
Despite the upcoming new drugs, Cyclosporine A (CsA) is
still one of the most important immunosuppressants in solid
organ transplantation. Due to its narrow therapeutic range,
the high intra- and interindividual variability of absorption
and metabolization, and the need of highly compliant daily
administration, long-termaccurateandfrequentmonitoring
of CsA concentrations is pivotal to avoid graft rejection
at underdose and nephrotoxicity at overdose. Since the
variation in CsA exposure is greatest during the absorption
phase in the ﬁrst 4- to 12-hour post-dose, the determination
of the pharmacokinetic area under the curve (AUC0–4,r e s p . ,
AUC0–12)[ 1, 2] provides an adequately precise measure
of drug exposure. However, AUC determination requires
multiplebloodsamplings;itisuncomfortableforthepatient,
expensive, and diﬃcult to perform in a routine clinical
setting. The commonly performed measurement of predose
CsA concentrations (C0) is, in contrast, less applicable for
CsA pharmacokinetic monitoring since it does not perfectly
correlate with CsA exposure as determined by AUC analysis,
and it does not predict nonoccurrence of graft rejection
[2]. In contrast, the CsA C2 (2 hours post-dose) peak
concentration highly correlates with AUC. Therefore, CsA2 Journal of Transplantation
C2 levels have been initially described as the optimal single-
time point marker for AUC [3–5]. However, C2 monitoring
bears some practical diﬃculties due to the narrow time
frameof ±15minforbloodsamplingperformedbyqualiﬁed
medical personnel. Hence, it is reasonable to shift the
sampling work to capable patients who can proﬁt from
the enhanced sampling accuracy, even when they stay
at home [6]. Novel mass spectrometric-based analytical
methods for the determination of CsA only require small
volumes of EDTA-whole blood (≤50μL). Therefore, self-
samplingsystemslikecapillariesordriedbloodspotsbecome
applicable for transplant patients. Our paper aimed at
the evaluation and comparison of feasible CsA C2 self-
sampling procedures for capillary EDTA and dried blood
in patients after solid organ transplantation with respect on
reproducibility, accuracy, sampling quality, and particularly
the patient-related practicability and acceptance.
2.Methods and Materials
2.1. Patients. 55 solid organ transplant recipients (42 renal, 2
combined renal/pancreas, 11 liver transplants; m/f 37/18; age
52 years ±10) from the outpatient clinic of the Transplant
Center of the University Hospital of Leipzig were recruited
for this paper. All patients received daily CsA dosing (120–
500mg/d), 42 patients additionally MMF and were on steady
state medication at least three months after transplantation.
The study was approved by the local ethics committee
and fulﬁlled all requirements of the latest amendment of
the Helsinki declaration. All patients declared their informed
consent.
2.2. Study Design. The study included three visits, number
1 and number 3 at the clinic, number 2 at home. Visit
number 1 comprised patients recruitment and training for
standardized self-sampling of capillary EDTA-whole blood
and dried blood, venous blood drawing, and exemplary
sampling of capillary blood and dried blood, as well as
delivering a prepared kit for home sampling. At visit number
2, about four weeks after visit number 1, patients obtained
capillarybloodanddriedbloodathomeandshippedittothe
laboratory using the prepared kits. Visit number 3 consisted
of venous sampling and supervised capillary self sampling
as well as ﬁlling out the questionnaire. Sampling quality of
all visits was controlled before analysis using a standardized
checklist. Blood specimens were assessed in the lab. by the
technicians with respect to sample quality.
2.3. Material. For capillary sampling we used mechanical
ﬁnger-prick devices (Accu-Check Softclix Pro, Roche Diag-
nostics, Mannheim, Germany), EDTA-coated capillary vials
(Microvette No 20.1278, Sarstedt, N¨ umbrecht, Germany),
and specimen collection ﬁlter paper (Whatman & Sch¨ ull
No 903, Whatman, Middlesex, UK). For dried blood spots,
capillary EDTA-blood was dropped on the ﬁlter paper and
air dried thereafter for at least 2h. Systems for venous blood
sampling (EDTA Monovette and Multiﬂy needle sets) were
obtained from Sarstedt (N¨ umbrecht, Germany). Postpaid
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Figure 1: Stability of CsA in dried blood spots at diﬀerent ambient
temperatures. Medians and 95% coverage intervals of eﬀective CsA




2.4. Analytical Methods. We determined CsA levels by liquid
chromatographytandemmassspectrometry(LC-MS/MS)in
venous and capillary EDTA-blood (50μL sample volume) as
previously described [7]. For the CsA analysis in dried blood
a 4mm diameter spot (corresponding blood volume 4μL)
was eluted with 100μL methanol containing Cyclosporine D
(CsD)asinternalstandard.Afterstirring(20min),CsAmea-
surements were performed using 35μL of the supernatant.
2.5. Patient Questionnaire. The patient-related practicability
was assessed by the following questions: Could you draw
capillarybloodwithouthelp?Ifnot,whendidyouneedhelp?
Do you prefer capillary or venous sampling? Do you prefer
capillary EDTA vials or specimen collection ﬁlter paper? Did
you encounter problems shipping the samples?
2.6.TechnicianQuestionnaire. Sampling qualitywasassessed
by the following criteria: sample volume, observed clotting,
proper ﬁlter, and paper dropping.
2.7. Statistics. Statistical analyses were performed using
MedCalc (Mariakerke, Belgium), SPSS (Chicago, USA), and
R [8] with the latticist package [9]. For correlation
analysis,Spearman’sρ coeﬃcientwascalculated.Signiﬁcance
of diﬀerences between groups was computed with the
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Figure 2: Absolute CsA C2 concentrations at all visits. Dotplots of absolute CsA C2 concentrations at all visits for renal ((a), including
renal/pancreas) and liver (b) transplant recipients. Signiﬁcant diﬀerences are highlighted in the respective colour (capillary blood = green,
dried blood = red, EDTA blood = blue). Lines represent medians.
Table 1: Correlations of venous and capillary CsA concentrations.























Correlations as Spearman’s ρ; ∗(P<. 05); ∗∗(P<. 01); Venous EDTA blood
VE; Capillary EDTA blood CE; Capillary Dried Blood CDB.
distribution was ensured using the one-sided Kolmogorov-
Smirnov test.
3. Results
3.1. CsA Concentrations in Capillary Blood Correlate with
Venous Levels. CsA C0 and C2 concentrations in venous
blood correlated signiﬁcantly with concentrations obtained
fromcapillaryEDTAbloodandtoalesserbutalsosigniﬁcant
extent with CsA concentrations derived from dried blood
spots (Table 1).
3.2. CsA Is Stable in Dried Blood Spots at 8◦C. 18 capillary
driedbloodsampleswithandwithoutEDTA-stabilizingwere
stored at 8◦Ca n d2 0 ◦C for 2, 4, 6, 12, and 24 hours and
analyzed thereafter (Figure 1). Samples were stable up to at
least 12 hours, a signiﬁcant diﬀerence (P = .013) in stability
between cooled and noncooled dried blood spots aroses,
Table 2: Absolute mean venous and capillary CsA concentrations
of all patients at all visits.
Visit Mat. C0 (μg/L) C2 (μg/L)
(1)
VE 95.1 ±28.7 586.0 ±247.2
CE 117.4 ±49.0 710.3 ±386.5
CDB 171.4 ±92.6 756.2 ±378.6
(2) CE 115.7 ±99.5 507.4 ±259.7
CDB 146.5 ±83.2 621.9 ±359.1
(3)
VE 97.8 ±37.4 511.2 ±201.5
CE 114.5 ±44.5 578.2 ±222.2
CDB 175.4 ±137.7 743.1 ±368.1
Absolute CsA C0 and C2 concentrations at all visits; Venous EDTA-Blood
VE; Capillary EDTA blood CE; Capillary Dried Blood CDB.
though,onlyatthe24htimepoint.The24htotaldecreasein
CsA concentrations was signiﬁcant in both groups (cooled:
P<. 05; noncooled: P<. 001). While EDTA failed to exert
stabilizing eﬀects in dried blood spots, neither did we ﬁnd
remarkable decomposition of CsA in capillary EDTA blood
samples nor is it mentioned in the recent literature [10, 11].
3.3. CsA Concentrations Depend on the Sample Material.
CsA measurement in capillary blood resulted in signiﬁ-
cantly higher CsA C0 and C2 levels compared to venous
blood. Dried blood spots yielded the highest concentrations
and variance (Table 2 and Figure 2). Based on the high
correlation to the venous concentrations and the linearity
of increase, the discrepancy might be overcome by the
introduction of a correction factor. We found a signiﬁcant
(P = .010) diﬀerence between CsA C2 concentrations in4 Journal of Transplantation
capillary blood when comparing the withdrawals performed
by a physician (visit 1) and by the patient at home (visit 2)
in renal transplant recipients, probably due to the awkward
handlingofthetubes.Inlivertransplantrecipients,therewas
a barely signiﬁcant (P = .043) diﬀerence between the CsA
C2 concentrations from self-obtained dried blood samples at
visit 2 and from samples under supervision drawns at the
transplant center at visit 3. We found also a slight decrease
(P = .048) of CsA C2 concentrations in EDTA blood from
visit 1 to visit 3 in renal transplant recipients (Figure 2).
3.4. Self-Sampling of Capillary Blood Is Feasible and Appre-
ciable for Transplant Patients. All patients considered them-
selves to be suﬃciently informed to perform capillary
sampling at home. 91% of the patients were able to obtain
blood without help. 61% prefered capillary sampling to
venous sampling, 30% were undecided. 65% versus 18%
prefered capillary dried blood to capillary EDTA sampling
due to facilitated handling. All patients drew capillary blood
from the ﬁnger pad, 13% encountered shipping problems
caused by the size of the shipping box pursuant to UN 3373.
The sample quality of the capillary samples was evaluated
by the lab technicians using a predeﬁned checklist. 83%
of the dried blood spots and 73% of the self-obtained




We observed adequate correlation of C0 and C2 levels
derived from capillary dried whole EDTA blood and the
capillary EDTA blood with the corresponding venous blood
samples as also stated by Keevil and Merton for the latter
[10, 12]. The weaker correlation of CsA C0 and C2 levels
measuredindriedbloodmightbecausedbythesmallsample
volume used for analysis (4μLv e r u s5 0 μL EDTA blood),
whichresultsineﬀectiveCsAconcentrationsbelow10ng/mL
in the processed sample. In this low concentration range
CsA contaminations of the internal standard CsD interfere
with the measurement [13]. Additionally, the blood volume
in the 4mm dried blood spot varies depending on the
individual hematocrit. Moreover, chromatographic eﬀects of
CsA (radial concentration gradient and increase of variance)
in the ﬁlter paper were observed [14]. Therefore, dried blood
should only be punched from the center of the blood spot to
restrain preanalytical variance.
Self-sampling may become an alternative of venous
blood taking in monitoring the steady state of CsA immuno-
suppression especially of outpatients. However, important
prerequisites should be kept in mind.
First, self-sampling should be performed in a highly
standardized way—thorough instruction and equivalent
training of the patients are indispensable. In our study, all
patients considered themselves as suﬃciently informed and
managed the sampling procedure—even without help—very
well as expressed by the high percentage (83% and 73%,
resp.) of samples suitable for analysis. The main problems
were inadequate sample volume (spots less than 4mm in
diameter, or air accidentally included in the capillary tube
and preventing further ﬁlling) and coagulation, especially in
the capillary EDTA systems. Since self-sampling is greatly
facilitatedusingﬁlterpaperandisperformedwithfavourable
sample quality, patients prefer this technique to the more
complicated handling of capillary EDTA vials, which were
used in the studies of Keevil, Yonan, and Merton [10–12].
Second, the analytical sensitivity of the dried blood
measurement of low-dose- CsA C0 levels can be enhanced by
the use of deuterated standards, which are available now or
by simply increasing sample volume requiring several blood
spots. However, CsA C2 concentrations range between 400–
1300ng/mL [1]. Hence, the use of capillary dried blood is
feasible for these patients.
Third, cool and rapid shipping is essential to restrain
CsA degradation. While 5-day stability of CsA in capillary
EDTA samples was shown by Yonan et al. [11], in our
study we could corroborate CsA stability only in dried
blood spots kept at 8◦C, whereas samples degraded after
one day when kept at room temperature (20◦C, Figure 1).
Interestingly, EDTA did not exert any stabilizing eﬀect on
CsA in dried blood spots. This degradation is a challenge for
the sample transport management demanding either same-
daydeliveryorwarrantingrefrigeratedtransportandstorage.
However, in contrast to capillary EDTA blood the dried
bloodsamplesareveryconvenientforshippingsinceasimple
paper envelope can be used instead of a larger, inexpedient,
and more expensive box.
Finally, reasonable correction factors should be applied
to maintain comparability with venous levels. As shown
in Figure 2, the self-obtained CsA C2 concentrations and
the undersupervision obtained ones correspond very well
and indicate that the self-monitoring performed by patients
at home is comparable to the monitoring performed at
specializedcenters.Theslightlysigniﬁcantdiﬀerenceindried
blood CsA C2 concentrations in liver transplant recipients
between visits 2 and 3 was not seen in renal transplant
recipients and might point at a still not suﬃcient training of
thepatients.Togetherwiththelinearityoftheincrease,which
may be adjusted by the introduction of correction factors,
capillary blood (EDTA blood or dried blood) was proved to
be an appropriate medium for steady-state CsA monitoring
in solid organ transplant patients [10–12].
Additionally, capillary blood samples could also be used
to determine further immunosuppressant drugs, ranging
from tacrolimus, sirolimus, and everolimus to MMF [6, 15,
16] or even creatinine as a correlate of renal transplant
functionandnephrotoxicityinrenalandnonrenaltransplant
recipients [12] in a single sample, which renders the method
favorable for pediatric transplant patients, where sampling is
frequently diﬃcult and cumbersome. From an economical
point of view, self-sampling at home can save expenses
for qualiﬁed ward personnel and travelling costs to the
outpatient wards. Additionally, the patient’s CsA monitoring
resultsmightbealreadyavailablewhenthepatientundergoes
his routine checkup.
Comparing our results for CsA C2 monitoring using
capillary EDTA blood with previous studies reveals analogueJournal of Transplantation 5
correlations with the results of the venous “gold standard”
method [10, 11]. However, there is only one publication
by Azevedo et al. investigating the feasibility of CsA C2
monitoring in dried blood, demonstrating a comparable
correlation of r = 0.81 for radioimmunological assays of
dried blood CsA C2 concentrations and routine CsA C2
determinations from venous whole blood though applying
a ﬁve times higher dried blood volume of 20μL[ 17].
Apart from the aforementioned advantages of CsA C2
montoringusingcapillaryblood,thereareseverallimitations
to be considered. The main constraint is the small sample
volume, especially favoured in pediatric patients, restricting
the number of parameters determined simultaneously and
demanding multiparametric methods. Moreover, the capil-
lary sample material is not suitable for many, in particular
for the hemolysis-sensitive parameters. The ﬁnite stability
of the analytes in dried blood might as well interfere with
the clinical use of dried blood monitoring as the elaborate
analytical methods.
Taking the above-mentioned factors into account, CsA
self-monitoring using capillary EDTA blood or capillary
dried blood spots is feasible and comfortable for transplant
patients—even at home—with respect on suﬃcient compa-
rability to venous blood, accuracy for clinical use, sampling
quality, and patient-related practicability.
5. Conclusion
C2 self-obtained blood sampling using EDTA-stabilized
capillary and dried blood spots can be easily performed
by transplant recipients and results in CsA measurements
acceptable for steady-state monitoring. The type of blood
sampling inﬂuences the respective CsA levels. However, the
patient-related intraprocedural variances of CsA measure-
ments are still appropriate for C2 monitoring in clinical
practice. Therefore, dried blood self-sampling is suitable for
Cyclosporine C2 monitoring in transplant outpatients
Abbreviations
CsA: Cyclosporine A
LC-MS/MS: Liquid chromatography/-tandem mass
spectrometry
MMF: Mofetil Mycophenolate
EDTA: Ethylene diamine tetra-acetate
AUC: Area under the curve
C0: CsA baseline concentration
C2: CsA 2-hour post-dose concentration.
Disclosures
All authors declare that no conﬂict of interest interferes with
the study. The results presented in this paper have not been
published previously in whole or part, except in abstract
format. This paper was supported by a research grant from
Novartis to JT and HW. The funder had no role in study
design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Short Summary
CsA self-monitoring using dried blood spots is feasible
and comfortable for transplant patients—even at home—
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